UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 27, 2021
Accession Number:
Submission Type:
CIK:
0000109657
Company Name:
GT Biopharma, Inc.
File Number:
333-255429